Attributes | Values |
---|
rdf:type
| |
description
| - artículu científicu espublizáu en 1997 (ast)
- vědecký článek publikovaný v roce 1997 (cs)
- 1997 թվականի մայիսին հրատարակված գիտական հոդված (hy)
- 1997 թուականի Մայիսին հրատարակուած գիտական յօդուած (hyw)
- наукова стаття, опублікована в травні 1997 (uk)
- مقالة علمية (نشرت في مايو 1997) (ar)
- vedecký článok (publikovaný 1997/05/01) (sk)
- article scientifique publié en 1997 (fr)
- scientific journal article (en)
- im Mai 1997 veröffentlichter wissenschaftlicher Artikel (de)
- wetenschappelijk artikel (gepubliceerd op 1997/05/01) (nl)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
OpenCitations bibliographic resource ID
| |
OpenCitations bibliographic resource ID
| |
author name string
| |
OpenCitations bibliographic resource ID
| |
rdfs:label
| - The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts (en)
- The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts (nl)
- The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts (ast)
|
skos:prefLabel
| - The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts (en)
- The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts (nl)
- The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts (ast)
|
name
| - The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts (en)
- The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts (nl)
- The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts (ast)
|
title
| |
title
| - The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
ResearchGate publication ID
| |
ResearchGate publication ID
| |
Springer Nature article ID
| |
Dimensions Publication ID
| |
Springer Nature article ID
| |
Dimensions Publication ID
| |
is about
of | |
is cites work
of | - Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis
- Costunolide, a sesquiterpene lactone from Saussurea lappa, inhibits the VEGFR KDR/Flk-1 signaling pathway
- The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway
- cis-hinokiresinol, a norlignan from Anemarrhena asphodeloides, inhibits angiogenic response in vitro and in vivo
- Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
- Microtubules coordinate VEGFR2 signaling and sorting
- Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome.
- Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast
- Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
- The type 2 vascular endothelial growth factor receptor recruits insulin receptor substrate-1 in its signalling pathway
- Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors
- Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice
- Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase
- Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
- Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments
- Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
- Axitinib--a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor
- The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells
- A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells
- Differential activation of vascular genes by hypoxia in primary endothelial cells.
- Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells
- Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase
- Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
- VEGFR and type-V RTK activation and signaling
- Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice.
- Differential regulation of VEGF signaling by PKC-alpha and PKC-epsilon in endothelial cells
- Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E.
- The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells
- Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148
- Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle
- Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.
- VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells
- Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization
- Growth factor signaling pathways in vascular development
- Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF
- FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition
- The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study
- ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
- Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth
- Signal transduction by VEGF receptor-1 wild type and mutant proteins
- A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylation
|